Comparison
Alpha-GPC vs Selank
Side-by-side of Alpha-GPC and Selank. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Alpha-GPC
Alpha GPC supplement profile: 300 to 600 mg dosage, acetylcholine synthesis, attention and reaction-time evidence, side effects, and choline donor comparisons.
Selank
Selank peptide benefits: tuftsin analog heptapeptide, intranasal anxiolytic and nootropic. Russian clinical data, dosing, half-life, safety.
Effects at a glance
Alpha-GPC
- •Choline donor supplement, roughly 40% choline by weight; crosses blood-brain barrier efficiently
- •Replicated small gains in attention and reaction time at 300 to 600 mg in healthy adults
- •Standard prescription cognitive medication in much of Europe (Gliatilin) at 1,200 mg/day for vascular cognitive impairment
- •ASCOMALVA trial (n=210) showed cognitive preservation when added to donepezil over 24 months
- •Increases acute power output (~14%, single trial) and transient growth hormone secretion at 600 mg
- •TMAO production raises a contested cardiovascular concern at chronic high doses
Selank
- •Synthetic heptapeptide analog of tuftsin developed in Russia in the 1990s
- •Approved in Russia for generalized anxiety disorder and asthenic conditions
- •Russian RCTs report anxiolytic effects comparable to medazepam without sedation or dependence
- •Modulates GABAergic and serotonergic signaling and BDNF expression in preclinical models
- •Most commonly administered intranasally; subcutaneous use is anecdotal
- •No Western-validated trials; not FDA approved; research-use-only outside Russia
Side-by-side
| Attribute | Alpha-GPC | Selank |
|---|---|---|
| Category | supplement | peptide |
| Also known as | L-Alpha glycerylphosphorylcholine, choline alfoscerate, GPC, alpha-glyceryl phosphorylcholine | TP-7, Tuftsin analog |
| Half-life (hr) ↗ | 4 | 0.5 |
| Typical dose (mg) ↗ | 600 | 0.4 |
| Dosing frequency | 1 to 3 times daily | 2-3x daily (intranasal) |
| Routes | oral | intranasal, subcutaneous |
| Onset (hr) | 1 | 0.25 |
| Peak (hr) | 2 | 1 |
| Molecular weight | 257.22 | 751.85 |
| Molecular formula | C8H20NO6P | C33H57N11O9 |
| Mechanism | Hydrolyzed to free choline and glycerophosphate after absorption; choline supports acetylcholine and phosphatidylcholine synthesis in CNS. | Modulates GABAergic, serotonergic, and dopaminergic signaling. Increases BDNF expression in hippocampal neurons in preclinical models. Modulates enkephalin levels and immune cytokine signaling via tuftsin-like activity. |
| Legal status | Dietary supplement (US); prescription medication in much of Europe | Approved as a prescription anxiolytic in Russia; not FDA approved; research-use-only grey market in most other jurisdictions |
| WADA status | allowed | unknown |
| DEA / Rx | OTC supplement | Not FDA approved; not scheduled; research-chemical status outside Russia |
| Pregnancy | Insufficient data; choline generally recommended in pregnancy | Not recommended; insufficient data |
| CAS | 28319-77-9 | 129954-34-3 |
| PubChem CID | 71920 | 11765600 |
| Wikidata | Q411478 | Q4416793 |
Safety profile
Alpha-GPC
Common side effects
- mild GI upset
- headache
- dizziness
- occasional insomnia with evening dosing
Contraindications
- established cardiovascular disease (TMAO concern)
- concurrent strong anticholinergic therapy
Interactions
- anticholinergic medications: partial mutual antagonism(minor)
- cholinesterase inhibitors (donepezil): additive cholinergic effect, basis for ASCOMALVA protocol(minor)
- scopolamine: partial counteraction of anticholinergic effect(minor)
Selank
Common side effects
- mild nasal irritation (intranasal)
- transient drowsiness (uncommon)
- mild headache
Contraindications
- pregnancy
- lactation
- severe psychiatric disorder (insufficient data)
Interactions
- benzodiazepines: additive anxiolytic effect; potential for over-sedation when stacked(moderate)
- SSRIs: no documented adverse interaction; co-administration described in Russian protocols(minor)
Which Should You Take?
Alpha-GPC comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Selank is the right call when one of the conditionals below applies.
- → If your priority is athletic performance, pick Alpha-GPC.
- → If your priority is choline supply, pick Alpha-GPC.
- → If your priority is anxiety reduction, pick Selank.
- → If your priority is mood, pick Selank.
Edge case: If you want to avoid research-only / gray-market sourcing, Alpha-GPC is the more accessible choice.
Default choice: Alpha-GPC. Lower friction to source, and broader goal coverage. Reach for Selank only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Alpha-GPC and Selank?
Alpha-GPC and Selank differ in category (supplement vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Alpha-GPC or Selank?
Alpha-GPC half-life is 4 hours; Selank half-life is 0.5 hours.
Can you stack Alpha-GPC with Selank?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper